Working... Menu

A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02057380
Recruitment Status : Completed
First Posted : February 7, 2014
Last Update Posted : September 3, 2018
Information provided by (Responsible Party):
Astellas Pharma Inc ( Astellas Pharma Global Development, Inc. )

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 14, 2016
  Actual Study Completion Date : December 21, 2016
  Certification/Extension First Submitted : October 2, 2017